MXPA06010539A - Method of stabilizing oxidizable color-assuming reagent - Google Patents
Method of stabilizing oxidizable color-assuming reagentInfo
- Publication number
- MXPA06010539A MXPA06010539A MXPA/A/2006/010539A MXPA06010539A MXPA06010539A MX PA06010539 A MXPA06010539 A MX PA06010539A MX PA06010539 A MXPA06010539 A MX PA06010539A MX PA06010539 A MXPA06010539 A MX PA06010539A
- Authority
- MX
- Mexico
- Prior art keywords
- reagent
- acid
- oxidizable color
- color development
- solution
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 41
- 230000000087 stabilizing Effects 0.000 title claims abstract description 6
- 238000011161 development Methods 0.000 claims description 31
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- -1 N-methylcarbamoyl Chemical group 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- DMBHHRLKUKUOEG-UHFFFAOYSA-N Diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 claims description 3
- AAAQKTZKLRYKHR-UHFFFAOYSA-N Triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- WJFKNYWRSNBZNX-UHFFFAOYSA-N Phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 claims 2
- 229950000688 Phenothiazine Drugs 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 239000000243 solution Substances 0.000 description 14
- 239000000975 dye Substances 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 8
- 101700049241 MCDP Proteins 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- SDKQRNRRDYRQKY-UHFFFAOYSA-N Dioxacarb Chemical compound CNC(=O)OC1=CC=CC=C1C1OCCO1 SDKQRNRRDYRQKY-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000011002 quantification Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940072417 Peroxidase Drugs 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- 108090000437 Peroxidases Proteins 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 210000004369 Blood Anatomy 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000002255 enzymatic Effects 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 150000004961 triphenylmethanes Chemical class 0.000 description 3
- 229940107161 Cholesterol Drugs 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000010909 EC 1.4.3.4 Human genes 0.000 description 2
- 108010062431 EC 1.4.3.4 Proteins 0.000 description 2
- 229940088598 Enzyme Drugs 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229960001031 Glucose Drugs 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229960002449 Glycine Drugs 0.000 description 2
- 108020005203 Oxidases Proteins 0.000 description 2
- 229940067631 Phospholipids Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Trioxopurine Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K Tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229940116269 Uric Acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000002990 phenothiazines Chemical class 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 229940066767 systemic antihistamines Phenothiazine derivatives Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- PHOLIFLKGONSGY-UHFFFAOYSA-N (3-methyl-1,3-benzothiazol-2-ylidene)hydrazine Chemical compound C1=CC=C2SC(=NN)N(C)C2=C1 PHOLIFLKGONSGY-UHFFFAOYSA-N 0.000 description 1
- GESUXCLRERRNSQ-UHFFFAOYSA-N 1-benzhydrylnaphthalene Chemical compound C1=CC=CC=C1C(C=1C2=CC=CC=C2C=CC=1)C1=CC=CC=C1 GESUXCLRERRNSQ-UHFFFAOYSA-N 0.000 description 1
- XUJZNKFIBZHDKL-UHFFFAOYSA-N 2-[[3,7-bis(dimethylamino)phenothiazine-10-carbonyl]amino]acetic acid Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3N(C(=O)NCC(O)=O)C2=C1 XUJZNKFIBZHDKL-UHFFFAOYSA-N 0.000 description 1
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-Diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2H-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-N,N-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- WZKXBGJNNCGHIC-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]-phenylmethyl]-N,N-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=CC=C1 WZKXBGJNNCGHIC-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N ABTS Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 102100001249 ALB Human genes 0.000 description 1
- 101710027066 ALB Proteins 0.000 description 1
- 229960003767 Alanine Drugs 0.000 description 1
- 229960005261 Aspartic Acid Drugs 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N Benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N Boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 229960003624 Creatine Drugs 0.000 description 1
- 229940109239 Creatinine Drugs 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 102000013587 Guanine Deaminase Human genes 0.000 description 1
- 108010012029 Guanine Deaminase Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N O-Phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N Phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- 229940107700 Pyruvic Acid Drugs 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N Tolidine Chemical class C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- NWCHELUCVWSRRS-UHFFFAOYSA-N atrolactic acid Chemical compound OC(=O)C(O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-UHFFFAOYSA-N 0.000 description 1
- BPYKTIZUTYGOLE-IFADSCNNSA-N bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine zwitterion Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 1
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 108091005980 glycated proteins Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- KJUGUADJHNHALS-UHFFFAOYSA-O hydron;2H-tetrazole Chemical class C1=NN=[NH+]N1 KJUGUADJHNHALS-UHFFFAOYSA-O 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000004987 o-phenylenediamines Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000276 potassium ferrocyanide Substances 0.000 description 1
- OCPOWIWGGAATRP-UHFFFAOYSA-N potassium hexacyanoferrate(4-) Chemical compound [K+].[K+].[K+].[K+].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N OCPOWIWGGAATRP-UHFFFAOYSA-N 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
Abstract
A method of storing/stabilizing an oxidizable color-assuming reagent, especially a leuco dye;and a stabilized reagent obtained thereby. The method of stabilizing an oxidizable color-assuming reagent comprises storing the oxidizable color-assuming reagent in a solution having a pH of 1 to 5.
Description
METHOD TO STABILIZE THE REAGENT FOR THE DEVELOPMENT OF OXIDIZED COLOR
TECHNICAL FIELD
The present invention relates to a method for stabilizing an oxidizable color development reagent to be used for testing the minor components of a biological sample, and to an oxidizable color development reagent stabilized by the method.
TECHNICAL BACKGROUND
The testing of several components contained in a biological sample, such as blood and urine, is essential for the diagnosis of the disease, clarification of the pathological conditions or evaluation of the therapeutic procedures, because said components are believed to be involved in some diseases. For example, there are methods that have been developed to test many varieties of minor components, such as blood cholesterol, triglycerides, glucose, uric acid, phospholipids, bile acid, and monoamine oxidase. These methods are used in the diagnosis of some diseases. Among the methods for testing serum components is the enzymatic method in which an enzyme that specifically acts on a
The target component becomes active, and its resulting product is tested for the determination of the quantity of the target component. This method is widely used. Among others, it is common to use a method wherein an oxidase that specifically acts on a target component is made to act on the component, to thereby generate hydrogen peroxide, and subsequently, a color development system is established through the contacting the generated hydrogen peroxide with an oxidizable color developing reagent (ie, a reagent that develops color when oxidized), and peroxidase (POD), thereby causing the reagent to develop color; and the amount of the objective component is determined through the colorimetric analysis of the color thus developed. Examples of oxidizable color development reagents employed in said enzymatic method include Trinder reagents, which is a phenolic, aniline, or toluidine chromogen, and forms a dye through oxidation-condensation with a coupler (e.g. aminotipyrine (4-AA) or 3-methyI-2-benzothiazolinonehydrazone (MBTH) in the presence of POD However, the color development system associated with said oxidizable color development reagent has some drawbacks, such as a low sensitivity for the quantification of minor components and their tendency to be affected by changes in the absorption spectrum attributed to hemoglobin, bilirubin, etc., contained in a sample to be tested In recent years, many reports have been published in order to overcome said drawbacks, with respect to oxidizable color development reagents including
leuco dye of triphenylmethane and a leuco dye of diphenylnaphthylmethane, which directly develops the color through oxidation in the presence of POD (see, for example, Patent Document 1). In addition, the triphenylmethane compounds are known to improve the low water solubility of the leuco dye (Patent Document 2). The leuco dyes are highly sensitive in tests, and in this way they are very useful compounds for the quantification of minor compounds. However, leuco dyes still have the problem that their storage stability is poor, therefore causing an unspecified, non-specific color development that occurs over time. Patent Document 1: JP-A-62-93261 Patent Document 2: JP-A-3-206896
BRIEF DESCRIPTION OF THE INVENTION
Problems to be solved through the invention Accordingly, an object of the present invention is to provide a method for stably storing an oxidizable color developing reagent, in particular, a leuco dye. Another object of the present invention is to provide a stabilized reagent through said method.
Means for solving the problems In view of the foregoing, the present inventors conducted extensive studies, and found that when an oxidizable color developing reagent is stored in a solution having a pH of 1 to 5, the oxidizable color development reagent It can be stably stored for a long period. In this way, the present invention was completed on the basis of this finding. Accordingly, the present invention provides a method for stabilizing an oxidizable color development reagent, which comprises storing the oxidizable color development reagent in a solution having a pH of 1 to 5. The present invention also provides a solution of oxidizable color development reagent having a pH of 1 to 5.
Effect of the invention According to the stabilization method of the present invention, an oxidizable color developing reagent can be stably stored in a solution for a long period. In addition, the use of an oxidizable color development reagent solution of the present invention enables the highly sensitive assay of a minor component of a biological sample. Accordingly, the oxidizable color development reagent solution of the present invention is very useful in the field of clinical examination.
DETAILED DESCRIPTION OF THE INVENTION
The oxidizable color development reagent solution of the present invention can be used in any oxidation substance quantification method that utilizes an oxidizable color development reagent as a color development component. Examples of the oxidation substance include hydrogen peroxide. The oxidizable color development reagent solution of the present invention is particularly useful for testing minor components of a biological sample, wherein an oxidase is made to act on a substrate or a substance generated through an enzymatic reaction, and the hydrogen peroxide thus generated is quantified. No particular limitation is imposed on the minor components contained in a biological and quantifiable sample through the use of the oxidizable color development reagent solution of the present invention. In this way, any biological component that can be assayed through the quantification of hydrogen peroxide generated as a result of the enzymatic reaction can become a measurement target of the present invention. Examples of said component include glycated proteins, glycated peptides, glycated amino acids, cholesterol, glucose, glycerin, triglyceride, free fatty acids, uric acid, phospholipids, sialic acid, bile acid, pyruvic acid, inorganic phosphorus, creatinine, creatine, GOT, GPT , monoamine oxidase, guanase, and
cholinesterase, etc. No particular limitation is imposed on the oxidizable color development reagent usable in the present invention. Examples of the reagent include a combination of 3-methyl-2-benzothiazolinonehydrazone (MBTH) and an aniline compound; Z, Z'-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS); leuco dyes; benzidine derivatives, o-tolidine derivatives, triallylimidazole derivatives, and o-phenylenediamine derivatives, etc. Of these reagents, leuco dyes are preferred. Examples of leuco dyes include triphenylmethane derivatives, phenothiazine derivatives, and diphenylamine derivatives, etc. Examples of triphenylmethane derivatives that can be used include highly water soluble compounds described in JP-A-3-206896 and JP-A-6-197795, examples of phenothiazine derivatives include the compounds described in JP-B-60- 33479, and examples of the diphenylamine derivatives include the compounds described in JP-B-60-33479 and JP-A-62-93261. Of these compounds, the preferred ones are malachite green leuco, crystal violet leuco, the sodium salt of N- (carboxymethyl-aminocarbonyl) -4,4'-bs (di-methalamino) -diphenylamine ( DA-64; Wako Puré Chemical Industries Ltd.), sodium salt of 10- (carboxymethyl-aminocarbonyl) -3,7-bis (dimethylamino) phenothiazine (DA-67: Wako Puré Chemical Industries Ltd.), 10- (N -methylcarbamoi!) - 3,7-bis (dimethylamino) -10H-phenothiazine (MCDP: product of Dojindo laboratories), and N, N, N ', N', N ", N" -hexa-3-sulfopropyl-4 , 4 ', 4"-triaminotriphenylmethane (TPM-PS: product of Dojindo laboratories), etc.
these dyes, TPM-PS, DA-64, DA-67, and MCDP are more preferred, with TPM-PS and MCDP being even more preferred. Other usable dyes include diaminobenzidine, tetramethylbenzidine, hydroxyphenylpropionic acid, and orthophenylenediamine, etc. In order to modify the pH, any suitable substance can be used as long as it can achieve an acidic pH. For example, inorganic acids such as hydrochloric acid, sulfuric acid, and phosphoric acid can be used; and organic acids such as glycine, phthalic acid, maleic acid, citric acid, succinic acid, oxalic acid, tartaric acid, acetic acid, and lactic acid. No particular limitation has been imposed on the concentration of the inorganic or organic acids, but the concentration is preferably 0.0001 to 1, 000 mM, particularly preferably 0.01 to 1, 000 mM. The pH can be from 1 to 5, but the pH from 1 to 4 is particularly preferred. No particular limitation has been imposed on the concentration of the oxidizable color development reagent contained in an oxidizable color development reagent solution. Preferably, the concentration is from 0.001 to 100 mM, more preferably from 0.001 to 50 mM. The oxidizable color development reagent solution of the present invention may also contain, for example, an anionic or nonionic surfactant, each having a polyoxyethylene structure; an enzyme to treat contaminants in the blood sample, a reaction control agent; a stabilizer; a protein
such as albumin; a salt such as sodium chloride, potassium chloride or potassium ferrocyanide; an amino acid such as glycine, lysine, alanine, aspartic acid, or glutamic acid; a tetrazolium salt to avoid the effects of a reduction of the substance; an antibiotic; an antiseptic agent such as sodium azide or boric acid, or a cationic surfactant. The amount of said additive may be appropriately determined with reference to known enzymatic quantification methods that utilize an oxidizable color development reagent. The oxidizable color development reagent solution of the present invention can be provided as contained in, for example, a glass container or a plastic container. The containers are preferably protected from light.
EXAMPLES
The present invention will now be described in greater detail with reference to the examples, which should not be construed as limiting the invention.
EXAMPLE 1 Stabilization test 1 for TPM-PS
TPM-PS was dissolved in each of the aqueous solutions described below to achieve a concentration of 60 μM, and stored at 37 ° C. Subsequently, the absorbance at 600 nm was measured by means of an automated analyzer (Model 7150, product of Hitachi, Ltd.). Table 1 shows the absorbance data measured at points in time of 0 (start), storage for 2 weeks, and storage for 3 weeks.
TABLE 1
PB-K: potassium phosphate solution.
As is evident from Table 1, the non-specific color development of TPM-PS was effectively suppressed in aqueous solutions of pH 1 to 5, indicating that TPM-PS is stable.
EXAMPLE 2 Stabilization test 2 for TPM-PS
TPM-PS was dissolved in each of the aqueous solutions described below to achieve a concentration of 100 μM, and the absorbance was measured at 600 nm. After each sample was stored at 25 ° C for 10 days, the absorbance was remeasured at 600 nm. Table 2 shows the difference between the absorbance measured immediately after sample preparation and that measured after 10 days of storage (referred to as "variation in 10 days (OD)").
TABLE 2
As is evident from Table 2, the variation of absorbance of TPM-PS remains on a small scale when stored in an aqueous solution with a pH of 1 to 5, indicated that TPM-PS is stably stored as a result.
EXAMPLE 3 Stability of MCDP
MCDP was dissolved in methanol to achieve a concentration of 4 mM, and the resulting MCDP-methanol was dissolved in each of the aqueous solutions described below supplemented with 0.1% Triton X-100, to achieve a concentration of 100 μm. The solutions were stored at 37 ° C for 24 hours. Subsequently, the absorbance at 600 nM was measured. The results are shown in table 3.
TABLE 3
As is evident from Table 3, the variation of the absorbance of MCDP is too small, and the non-specific color development of MCDP is effectively suppressed when stored in an aqueous solution of pH from 1 to 5, indicating that MCDP is Can store stably.
Claims (7)
1. - A method for stabilizing an oxidizable color development reagent, which comprises storing an oxidizable color developing reagent in a pH solution of 1 to 5.
2. The method according to claim 1, further characterized in that the reagent Oxidizable color development is a leuco dye selected from a leuco dye of triphenylmethane, a leuco dye of phenothiazine, and a leuco diphenylamine dye.
3. The method according to claim 2, further characterized in that the leuco dye of triphenylmethane is N, N, N ', N', N ", N" -hexa-3-sulfopropyl-4,4 ', 4" -triaminotriphenylmethane 4.- The method according to claim 2, further characterized in that the leuco dye phenothiazine is 10- (N-methylcarbamoyl) -3,7-bis (dimethylamino) -1 OH-phenothiazine or 10- (carboxymethyl) -aminocarbonyl) -3,7-bis (dimethylamino) phenothiazine 5. The method according to any of claims 1 to 4, further characterized in that the pH solution of 1 to 5 contains one or more species selected from among acid hydrochloric acid, sulfuric acid, phosphoric acid, and organic acids 6. The method according to claim 5, further characterized in that the organic acid is maleic acid or citric acid. 7. A solution of an oxidizable color development reagent, characterized in that the solution has a pH of 1 to 5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-076015 | 2004-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06010539A true MXPA06010539A (en) | 2007-04-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080241816A1 (en) | Method for Stabilizing Oxidizable Color Developing Reagent | |
US5516700A (en) | Automated urinalysis method | |
JP5955220B2 (en) | Method for measuring glycated hemoglobin | |
JP6435605B2 (en) | Biological component measuring method and measuring composition | |
JP2016019498A (en) | Biogenic component measurement method and measurement composition therefor | |
CN103261434B (en) | Measure the assay method of object component | |
JP2013102736A (en) | Specimen for biochemical analysis, improved in pigment stability | |
JPH07121901B2 (en) | Novel urea derivative and measuring method using the same as a coloring component | |
JP7484998B2 (en) | Biological component measurement kit and biological component measurement method with improved measurement sensitivity | |
JP2013108872A (en) | Glycosylated hemoglobin measurement method and measurement kit | |
JP4639287B2 (en) | Stabilization method for enzymatic measurement reagents | |
JP4392486B2 (en) | Analysis method of haptoglobin | |
JP4691627B2 (en) | Method for suppressing non-specific color development | |
MXPA06010539A (en) | Method of stabilizing oxidizable color-assuming reagent | |
JPWO2006030866A1 (en) | Method for quantitative determination of uric acid | |
JP2013106572A (en) | Method for measuring glycated hemoglobin and measuring kit | |
JPH07155196A (en) | Method for measuring biological component | |
JP7195847B2 (en) | Measurement of glycated protein | |
JPH0372280B2 (en) | ||
JP2013104007A (en) | Method for stabilizing leuco dye | |
JPH04200396A (en) | High-sensitivity enzymatic determination of hydrogen peroxide and reagent therefor | |
JPS58187858A (en) | Stabilization of oxidation-receiving color identification reagent | |
JP2012024014A (en) | Method for measuring choline in whole blood | |
CN109837270A (en) | A method of keep myo-Inositol dehydrogenase, Ketoamine oxidase and sphingomyelinase steady in a long-term in a liquid | |
WO2022054890A1 (en) | Method for reducing measurement error |